Anakinra for the treatment of acute severe gout in critically ill patients

Seminars in Arthritis and Rheumatism
Jessica T ThueringerElie Gertner

Abstract

To report on the efficacy and safety of anakinra for treatment of acute gouty arthritis in medically complex, critically ill patients. Retrospective chart review of 13 critically ill hospitalized patients treated with anakinra for 20 episodes of acute gouty arthritis between 2009 and 2014 at a single health plan and institution (HealthPartners Medical Group and Regions Hospital) in Saint Paul, Minnesota. Data was obtained on baseline characteristics, medical comorbidities, reason for hospitalization, prior gout treatment, reason for choosing anakinra over standard therapy, anakinra dosing, response to treatment, and adverse outcomes. A total of 10 patients were in the Intensive Care Unit, 1 was in the Burn Unit for extensive 3rd degree burns, 1 was critically ill with a new diagnosis of hemophagocytic lymphohistiocytosis, and 1 was critically ill in isolation with active disseminated multidrug-resistant tuberculosis. Of these patients, 85% had active infections and 92% had renal insufficiency. All patients had a significant response to anakinra treatment: 50% (10/20 episodes) within 24h, an additional 40% (8/20 episodes) by 48h, and the remaining 10% (2/20 episodes) by 72h. Anakinra was well tolerated with only 1 case of leukop...Continue Reading

References

Jan 13, 2006·Nature·Fabio MartinonJürg Tschopp
Mar 14, 2007·Arthritis Research & Therapy·Alexander SoJürg Tschopp
May 8, 2013·Arthritis Care & Research·Pradipta GhoshGregory C Gardner
Jan 17, 2014·Arthritis Research & Therapy·Sébastien OttavianiPhilippe Dieudé

❮ Previous
Next ❯

Citations

Apr 8, 2014·Rheumatic Diseases Clinics of North America·Naomi Schlesinger
Jul 12, 2017·Expert Opinion on Pharmacotherapy·Tristan Pascart, Pascal Richette
Feb 13, 2018·Drugs & Aging·Eliseo PascualMariano Andrés
Mar 11, 2018·Rheumatology and Therapy·Daniela MarottoStefano Del Giacco
Oct 3, 2017·Rheumatology·Kristen Davies, Marwan A S Bukhari
Jul 3, 2019·The Journal of Rheumatology·Robert T Keenan
Jan 17, 2019·The Journal of Rheumatology·Jean W Liew, Gregory C Gardner
Sep 1, 2017·Expert Opinion on Drug Safety·Marta Pérez-De-LisManuel Ramos-Casals
Dec 17, 2019·Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders·Ena SharmaRobert Terkeltaub
Jun 12, 2020·Clinical Microbiology Reviews·Joshua S DavisMichael Boyle
Mar 17, 2018·Rheumatology·Tristan Pascart, Frédéric Lioté
Mar 13, 2021·Frontiers in Pharmacology·Hana MalcovaRudolf Horvath
Apr 16, 2021·International Journal of Immunopathology and Pharmacology·Silvia StefaniaFrancesco Paolo Cantatore

❮ Previous
Next ❯

Related Concepts

Related Feeds

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Related Papers

Cincinnati Journal of Medicine
J H TALBOTT
The Journal of the American Dental Association
D Resnick
Chinese Medical Journal
C J CHANG
© 2021 Meta ULC. All rights reserved